180 related articles for article (PubMed ID: 36210467)
1. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis.
Kathrikolly T; Nair SN; Mathew A; Saxena PPU; Nair S
Syst Rev; 2022 Oct; 11(1):215. PubMed ID: 36210467
[TBL] [Abstract][Full Text] [Related]
2. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.
Xia J; Shi J; Wang P; Song C; Wang K; Zhang J; Ye H
Scand J Immunol; 2016 Jun; 83(6):393-408. PubMed ID: 26991924
[TBL] [Abstract][Full Text] [Related]
3. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
4. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.
Manzotti C; Casazza G; Stimac T; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012546. PubMed ID: 31283001
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
6. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
[TBL] [Abstract][Full Text] [Related]
7. Imaging modalities to inform the detection and diagnosis of early caries.
Walsh T; Macey R; Riley P; Glenny AM; Schwendicke F; Worthington HV; Clarkson JE; Ricketts D; Su TL; Sengupta A
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD014545. PubMed ID: 33720395
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
Piura E; Piura B
J Oncol; 2011; 2011():982425. PubMed ID: 21423545
[TBL] [Abstract][Full Text] [Related]
9. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis.
Qin J; Zeng N; Yang T; Wan C; Chen L; Shen Y; Wen F
Cell Physiol Biochem; 2018; 51(6):2631-2646. PubMed ID: 30562746
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.
Lu H; Ladd J; Feng Z; Wu M; Goodell V; Pitteri SJ; Li CI; Prentice R; Hanash SM; Disis ML
Cancer Prev Res (Phila); 2012 Aug; 5(8):1036-43. PubMed ID: 22715141
[TBL] [Abstract][Full Text] [Related]
13. Visual or visual-tactile examination to detect and inform the diagnosis of enamel caries.
Macey R; Walsh T; Riley P; Glenny AM; Worthington HV; O'Malley L; Clarkson JE; Ricketts D
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD014546. PubMed ID: 34124773
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
Laidi F; Bouziane A; Errachid A; Zaoui F
Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
[TBL] [Abstract][Full Text] [Related]
17. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH
J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
Burford B; Gentry-Maharaj A; Graham R; Allen D; Pedersen JW; Nudelman AS; Blixt O; Fourkala EO; Bueti D; Dawnay A; Ford J; Desai R; David L; Trinder P; Acres B; Schwientek T; Gammerman A; Reis CA; Silva L; Osório H; Hallett R; Wandall HH; Mandel U; Hollingsworth MA; Jacobs I; Fentiman I; Clausen H; Taylor-Papadimitriou J; Menon U; Burchell JM
Br J Cancer; 2013 May; 108(10):2045-55. PubMed ID: 23652307
[TBL] [Abstract][Full Text] [Related]
19. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
